The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV). Methods: This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS (as defined by the Berlin criteria) affected with with COVID-19 (confirmed SARS-CoV-2 infection in nasal or pharyngeal swab specimens), admitted to a network of 36 Spanish and Andorran intensive care units (ICUs) between March 12 and June 1, 2020. We examined the clinical features, ventilatory management, and clinical outcomes of COVID-19 ARDS patients, and compared some results with other relevant studies in non-COVID-19 ARDS patients. Results: A total of 742 patients were analysed with complete 28-day outcome data: 128 (17.1%) with mild, 331 (44.6%) with moderate, and 283 (38.1%) with severe ARDS. At baseline, defined as the first day on invasive MV, median (IQR) values were: tidal volume 6.9 (6.3-7.8) ml/kg predicted body weight, positive end-expiratory pressure 12 (11-14) cmH 2 O. Values of respiratory system compliance 35 (27-45) ml/cmH 2 O, plateau pressure 25 (22-29) cmH 2 O, and driving pressure 12 (10-16) cmH 2 O were similar to values from non-COVID-19 ARDS patients observed in other studies. Recruitment maneuvers, prone position and neuromuscular blocking agents were used in 79%, 76% and 72% of patients, respectively. The risk of 28-day mortality was lower in mild ARDS [hazard ratio (RR) 0.56 (95% CI 0.33-0.93), p = 0.026] and moderate ARDS [hazard ratio (RR) 0.69 (95% CI 0.47-0.97), p = 0.035] when compared to severe ARDS. The 28-day mortality was similar to other observational studies in non-COVID-19 ARDS patients. Conclusions: In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.

No abstract

Industrially available blue ceramic pigments, with the exception of vanadium-zircon blue, (Zr,V)SiO 4 , contain Co. To minimise the use of toxic and scarce cobalt, while also maintaining an intense blue colour, the performance as blue ceramic pigments of both Co 2+ -Zn 2 SiO 4 (willemite) and Zn 2+ -Co 2 SiO 4 (olivine) solid solutions was studied. The addition of cobalt in the willemite lattice was minimised. A wide range of compositions, Co x Zn 22x SiO 4 (x = 2, 1.95, 1.5, 1, 0.9, 0.5, 0.05 and 0), were prepared and characterised by X-ray diffraction, lattice parameter measurements, UV-VIS-NIR spectroscopy, CIE-L*a*b* colour measurements and electronic microscopy (SEM/EDAX). The results show that an intense and more blue ceramic pigment is obtained based on the willemite lattice, with an optimised, low Co content, ranging from 25 mol% Co (Co 0.5 Zn 1.5 SiO 4 ) to 2.5 mol% Co (Co 0.05 Zn 1.95 SiO 4 ). This last composition (with only 2.5 mol% Co) exhibits the best blue hue once enamelled (b* = 239), though it is also considerably lighter (L* = 57).

No abstract

No abstract